Absci and Caltech collaborate to accelerate affordable HIV therapeutic vaccine
On Aug. 10, 2023, drug creation company Absci Corporation (ABSI) announced that its collaborative effort with the California Institute of Technology (Caltech) has received a grant from the Bill & Melinda Gates foundation. Led by Dr. Pamela Bjorkman, the collaboration combines research capabilities and advanced technological expertise in structural biology,